about
Lipid abnormalities in kidney disease and management strategiesWnt5a Deficiency Leads to Anomalies in Ureteric Tree Development, Tubular Epithelial Cell Organization and Basement Membrane Integrity Pointing to a Role in Kidney Collecting Duct PatterningLong-term effects of spironolactone in peritoneal dialysis patientsWhy do young people with chronic kidney disease die early?Risk factors associated with brachial-ankle pulse wave velocity among peritoneal dialysis patients in Macao.Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solutionRelationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography.Higher peritoneal protein clearance as a risk factor for cardiovascular disease in peritoneal dialysis patientShould peritoneal resting be advised in ultrafiltration failure associated with a fast peritoneal solute transport status?Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysisThe relationship between apelin and cardiac parameters in patients on peritoneal dialysis: is there a new cardiac marker?High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.Hyponatremia Predicts New-Onset Cardiovascular Events in Peritoneal Dialysis Patients.Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients.Relationship between CRP polymorphism and cardiovascular events in Chinese peritoneal dialysis patientsBiphasic Regulation of Lipid Metabolism: A Meta-Analysis of Icodextrin in Peritoneal Dialysis.Abdominal Obesity and Mortality in Continuous Ambulatory Peritoneal Dialysis Patients.Visceral fat area is associated with HbA1c but not dialysate-related glucose load in nondiabetic PD patients.High Serum Phosphorus Level Is Associated with Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis PatientsAn Increase of Plasma Advanced Oxidation Protein Products Levels Is Associated with Cardiovascular Risk in Incident Peritoneal Dialysis Patients: A Pilot StudyPrevalence and risk factors associated with peripheral artery disease in elderly patients undergoing peritoneal dialysis.China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysisWAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs.Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients.Protective measures against ultrafiltration failure in peritoneal dialysis patientsAn update on peritoneal dialysis solutions.Peritoneal dialysis as compared with hemodialysis is associated with higher overhydration but non-inferior blood pressure control and heart function.Improving the quality of a peritoneal dialysis service: learning from experience.Association of Body Mass Index With Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis.Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.The value of time-averaged serum high-sensitivity C-reactive protein in prediction of mortality and dropout in peritoneal dialysis patients.Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period.Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.Analysis of Ultrafiltration Failure Diagnosed at the Initiation of Peritoneal Dialysis with the Help of Peritoneal Equilibration Tests with Complete Drainage at Sixty Minutes. A Longitudinal Study.Coronary Artery Calcification Score as A Predictor of All-Cause Mortality and Cardiovascular Outcome in Peritoneal Dialysis Patients.Impact of peritoneal dialysis treatment on arterial stiffness and vascular changes in diabetic type 2 and nondiabetic patients with end-stage renal disease.Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.The Impact of Timing of Dialysis Initiation on Mortality in Patients with Peritoneal Dialysis.Relationship between myeloid-related protein 8/14 and survival of Chinese peritoneal dialysis patients.Phosphate Removal by Peritoneal Dialysis: The Effect of Transporter Status and Peritoneal Dialysis Prescription.
P2860
Q27024982-E56E1FC2-7B47-4802-8473-5FFD23807389Q27329684-9C31B33E-EC33-4ACB-9966-27AD3D3CAAE5Q30413119-DA137077-9F5E-4D94-9EFB-6BD94FB42F61Q34453230-6CE6AC89-E3A7-4FB5-9E0B-030A5134132AQ34462607-E55DB2B1-1F7A-4D78-9F6E-DF8D3B88A307Q34505567-C3CF807D-EC31-4C5C-9937-4083ED238F3FQ34508691-0DDFA547-B9BA-4D7C-9789-287CFF62F07FQ34589912-206BF4DA-B23A-465B-A2CA-37576AC692CFQ34725057-2AF89279-8C81-473A-829E-4A15A7FE7D2EQ34857892-863B382E-AEF6-47A7-AF0C-256408CF1CE4Q35085476-D8BD6BF6-5FD8-497A-BC41-A36CC7431EC8Q35131398-CDC5114B-1157-433C-A352-54ADA79EE9D3Q35656674-913D04C8-A933-436D-9954-4CBF64510122Q35695757-4F42FC59-DFF9-4557-A06F-92C8D037E95CQ35758519-C299B9E2-A7B4-4426-BD14-E3F315996359Q35898688-AF1AB19F-FAE7-4900-95CA-2A7DBDD1DC18Q35904961-0B06DF90-2B88-4A92-A852-BC74C2BAA7C2Q35913277-4C2B3353-598D-42DA-8366-00C4E33F561EQ36142874-1C8D1A59-4CDD-4443-AA7E-B6A7FCF08B4BQ36260030-D2315618-0474-4932-9154-34CBD303E553Q36344799-68766689-735C-4376-82BF-4258ADC1108BQ36411641-76B525E7-6B16-4A90-BC7F-8905DC593F61Q36966966-D5864D4D-BDEF-4A6D-B9A4-418DE9619F50Q37260188-9D5F2F04-0718-4CC3-A4A2-692D317D4B08Q37970606-91C3ACC1-75D2-495D-B7BB-D8A3CA14BB82Q37986357-7E2BE709-E0D7-47B4-824D-DCB3C3EC2125Q38038037-B8B0D73F-193A-4853-ACE2-E72398569F98Q38086929-4DEE5C17-C430-44A1-8B57-6E44A5B6B389Q38609652-BE0EF39A-EB90-42E2-AD33-AE8B03E77290Q39532143-0D8B9493-04B2-4CEE-9F17-CD697ACACBBEQ40071655-F64364C0-FF44-4C38-B42C-A6FBF819790BQ40603629-BFFCF50E-9937-4A29-9B3B-C53E5AEB6587Q40621855-8F7B3427-2DFC-49D5-AA07-2E56B01A1778Q40834171-703734FB-20CD-47A4-9CD4-5AF2B85D1350Q41531909-1577B0E8-984E-494D-82BA-CF3A79062A9FQ41812265-4845B7E7-E984-4548-98F5-5394DBD9F9DAQ42797339-A8F90BCE-659B-4821-B6BB-48FD7FF14FCFQ45193878-EE734138-9486-4CFE-B234-8807D07BAC07Q45369368-920870DA-5101-465A-B664-C3521823AE9CQ50531608-960F4FF0-72B9-437D-8C33-84528C446678
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular risk in the peritoneal dialysis patient.
@en
Cardiovascular risk in the peritoneal dialysis patient.
@nl
type
label
Cardiovascular risk in the peritoneal dialysis patient.
@en
Cardiovascular risk in the peritoneal dialysis patient.
@nl
prefLabel
Cardiovascular risk in the peritoneal dialysis patient.
@en
Cardiovascular risk in the peritoneal dialysis patient.
@nl
P2860
P921
P356
P1476
Cardiovascular risk in the peritoneal dialysis patient.
@en
P2093
Olga Balafa
Raymond T Krediet
P2860
P2888
P304
P356
10.1038/NRNEPH.2010.68
P407
P577
2010-06-22T00:00:00Z